Abstract
Objective: Despite the positive effects of decreased right ventricular afterload after implantation of a left ventricular assist device, the right ventricle may also sustain negative effects through changes in position of the interventricular septum and perioperative tricuspid regurgitation. Right ventricular failure, which occurs in 20–50 % of patients after left ventricular assist device implantation, is associated with substantial operative mortality and morbidity. Methods: This article reviews the pathology of and risk factors and management strategies for right ventricle failure after left ventricular assist device implantation. Results: Risk factors are female gender, non-ischemic cardiomyopathy, and preoperative mechanical support or intra-aortic balloon pumping; however, the significance of these findings was limited. Risk scoring systems have been developed to quantify this risk. Inotropes that induce pulmonary vasodilation, e.g., milrinone, accompanied by inotropes that increase systolic blood pressure, i.e., epinephrine, for coronary perfusion, are effective treatments for right ventricular failure. A specific pulmonary vasodilator, such as inhaled nitric oxide, which reduces pulmonary vascular resistance and increases device flow, is another important component of therapy. Because valvular pathologies can complicate postoperative management, correction of tricuspid regurgitation is necessary to decrease venous congestion and improve right ventricle function. Conclusions: Meticulous attention should be paid to optimizing preload, afterload, and contractility in patients with preexisting right ventricular dysfunction in order to prevent right ventricle failure after left ventricular assist device implantation. For intraoperative right ventricle failure, alternative measures of mechanical support, including a right ventricular assist device as a last resort, are used.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.
Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.
Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–21.
Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163–72.
Fitzpatrick 3rd JR, Frederick JR, Hsu VM, Hiesinger W, McCormick RC, Kozin ED, et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg. 2009;137:971–7.
Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile Heart Mate I and axial-flow Heart Mate II devices. Ann Thorac Surg. 2008;86:832–40. Discussion – 40.
Hennig F, Stepanenko AV, Lehmkuhl HB, Kukucka M, Dandel M, Krabatsch T, et al. Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device. Gen Thorac Cardiovasc Surg. 2009;59:19–24.
Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.
Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, et al. Right heart failure and “failure to thrive” after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant. 2011;30:888–95.
Santambrogio L, Bianchi T, Fuardo M, Gazzoli F, Veronesi R, Braschi A, et al. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg. 2006;5:379–82.
Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436–48.
Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114:1883–91.
Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham Jr TP. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson. 1999;1:7–21.
Walker LA, Buttrick PM. The right ventricle: biologic insights and response to disease. Curr Cardiol Rev. 2009;5:22–8.
Kevin LG, Barnard M. Right ventricular failure. Oxford J. 2007;7(3):89–94.
Pfisterer M. Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet. 2003;362:392–4.
John R, Lee S, Eckman P, Liao K. Right ventricular failure–a continuing problem in patients with left ventricular assist device support. J Cardiovasc Transl Res. 2010;3:604–11.
Thunberg CA, Gaitan BD, Arabia FA, Cole DJ, Grigore AM. Ventricular assist devices today and tomorrow. J Cardiothorac Vasc Anesth. 2010;24:656–80.
Lee S, Kamdar F, Madlon-Kay R, Boyle A, Colvin-Adams M, Pritzker M, et al. Effects of the Heart Mate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant. 2010;29:209–15.
Greyson CR. Pathophysiology of right ventricular failure. Crit Care Med. 2008 Jan;36(1 Suppl):S57–65.
Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6.
Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010;105:1030–5.
Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106(12 Suppl. 1):I198–I202.
Potapov EV, Stepanenko A, Dandel M, Kukucka M, Lehmkuhl HB, Weng Y, et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 2008;27:1275–81.
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713. quiz 86–8.
Mertens LL, Friedberg MK. Imaging the right ventricle–current state of the art. Nat Rev Cardiol. 2010;7:551–63.
Estep JD, Stainback RF, Little SH, Torre G, Zoghbi WA. The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. JACC Cardiovasc Imaging. 2010;3:1049–64.
Puwanant S, Hamilton KK, Klodell CT, Hill JA, Schofield RS, Cleeton TS, et al. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant. 2008;27:1102–7.
Meineri M, Van Rensburg AE, Vegas A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol. 2012;26:217–29.
Van Meter Jr CH. Right heart failure: best treated by avoidance. Ann Thorac Surg. 2001;71(3 Suppl):S220–2.
Fitzpatrick 3rd JR, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27:1286–92.
Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg. 2003;125:855–62.
Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27:1065–72.
Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant. 2009;28:827–33.
Kaplon RJ, Gillinov AM, Smedira NG, Kottke-Marchant K, Wang IW, Goormastic M, et al. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant. 1999;18:346–50.
Goldstein DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg. 1995 May;59:1063–67. Discussion 8.
Morgan JA, John R, Rao V, Weinberg AD, Lee BJ, Mazzeo PA, et al. Bridging to transplant with the HeartMate left ventricular assist device: the Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg. 2004;127:1309–16.
Neuzil P, Kmonicek P, Skoda J, Reddy VY. Temporary [short-term] percutaneous left ventricular assist device [Tandem Heart] in a patient with STEMI, multivessel coronary artery disease, cardiogenic shock and severe peripheral artery disease. Acute Card Care. 2009;11:146–50.
Boeken U, Feindt P, Litmathe J, Kurt M, Gams E. Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP Support. J Thorac Cardiovasc Surg. 2009;57:324–8.
Wagner F, Dandel M, Gunther G, Loebe M, Schulze-Neick I, Laucke U et al. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation 1997; 96: II–6.
Haddad E, Lowson SM, Johns RA, Rich GF. Use of inhaled nitric oxide perioperatively and in intensive care patients. Anesthesiology. 2000;92:1821–5.
Prasad S, Wilkinson J, Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Engl J Med. 2000;343:1342.
Klodell Jr CT, Morey TE, Lobato EB, Aranda Jr JM, Staples ED, Schofield RS, et al. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg. 2007;83:68–71.
SchenkS, McCarthy PM, Blackstone EH, et al. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg 2006; 131: 447–54.
Rao V, Slater JP, Edwards NM, Naka Y, Oz MC. Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg. 2001;71:1448–53.
Krishan K, Nair A, Pinney S, Adams DH, Anyanwu AC. Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardiothorac Surg. 2012;41:213–7.
Piacentino 3rd V, Troupes CD, Ganapathi AM, Blue LJ, Mackensen GB, Swaminathan M, et al. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. Ann Thorac Surg. 2011;92:1414–8. Discussion 8–9.
Maltais S, Topilsky Y, Tchantchaleishvili V, McKellar SH, Durham LA, Joyce LD, et al. Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2012;143: 1370–76.
Potapov EV, Sodian R, Loebe M, Drews T, Dreysse S, Hetzer R. Revascularization of the occluded right coronary artery during left ventricular assist device implantation. J Heart Lung Transplant. 2001;20:918–22.
Van Meter Jr CH, Robbins RJ, Ochsner JL. Technique of right heart protection and deairing during HeartMate vented electric LVAD implantation. Ann Thorac Surg. 1997;63:1191–2.
Loebe M, Potapov E, Sodian R, Kopitz M, Noon GP. A safe and simple method of preserving right ventricular function during implantation of a left ventricular assist device. J Thorac Cardiovasc Surg. 2001;122:1043.
Sun BC, Firstenberg MS, Louis LB, Panza A, Crestanello JA, Sirak J, et al. Placement of long-term implantable ventricular assist devices without the use of cardiopulmonary bypass. J Heart Lung Transplant. 2008;27:718–21.
Ghodsizad A, Kar BJ, Layolka P, Okur A, Gonzales J, Bara C, et al. Less invasive off-pump implantation of axial flow pumps in chronic ischemic heart failure: survival effects. J Heart Lung Transplant. 2011;30:834–7.
Woo YJ, Acker MA. Implantable ventricular assist device exchange with focused intravascular deairing techniques. Ann Thorac Surg. 2011;91:306–7.
Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30:115–23.
Morgan JA, John R, Lee BJ, Oz MC, Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg. 2004;77:859–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Nonaka, M., Rao, V. (2014). Strategies to Assess and Minimize Right Heart Failure After Left Ventricular Assist Device Implantation. In: Kyo, S. (eds) Ventricular Assist Devices in Advanced-Stage Heart Failure. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54466-1_7
Download citation
DOI: https://doi.org/10.1007/978-4-431-54466-1_7
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54465-4
Online ISBN: 978-4-431-54466-1
eBook Packages: MedicineMedicine (R0)